Here, we will discuss key biomarkers with clinical relevance in ovarian cancer, namely breast cancer susceptibility genes 1 and 2 (BRCA), human epidermal growth factor receptor 2 (HER2), trophoblast cell surface antigen 2 (TROP2), and folic acid receptor alpha (FOLR1). This evidence concerns the gene TACSTD2 and ovarian cancer.